Jump to content

20250228953. Intracellular Targe (Entrada Therapeutics, .)

From WikiPatents

INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES

Abstract: compounds are provided include a cell penetrating peptide, a therapeutic oligonucleotide, and a carbohydrate targeting moiety. the compounds may also include an exocyclic peptide. the compounds may be targeted to liver cells. the therapeutic oligonucleotide may be an oligonucleotide for treating a disease or disorder associated with a liver cell.

Inventor(s): Ziqing Qian, Mahboubeh Kheirabadi, Matthew Streeter

CPC Classification: A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers ))

Search for rejections for patent application number 20250228953


Cookies help us deliver our services. By using our services, you agree to our use of cookies.